Ivan Hyep sold $783K of Bicara Therapeutics (BCAX)

Executed Jul 8, disclosed Jul 10, 2 days later.

Value, as filed

$783K

27,170 sh across 2 lots

Executed

Jul 8

the trade date, as filed

Disclosed

Jul 10

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Ivan Hyep Chief Financial Officer profile →

Ivan Hyep (Chief Financial Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $783K of BCAX (27,170 sh across 2 lots, as filed), executed Jul 8.

The name

BCAX

Bicara Therapeutics Inc. BCAX · Healthcare · 40 filings in 24 months ticker →

Healthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ivan Hyep in BCAX

BCAXSALE Bicara Therapeutics Inc. $350K
12,500 sh × $27.97
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. $188K
9,200 sh × $20.42
Exec May 21
Filed May 26 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $212K
9,200 sh × $23.00
Exec Apr 21
Filed Apr 22 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $170K
9,200 sh × $18.52
Exec Mar 23
Filed Mar 24 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $247K
13,555 sh × $18.22
Exec Mar 3
Filed Mar 5 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $168K
9,200 sh × $18.31
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $330K
17,795 sh × $18.55
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $117K
6,415 sh × $18.23
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET